Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finegood, D. T.
Right arrow Articles by Vranic, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finegood, D. T.
Right arrow Articles by Vranic, M.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 36, Issue 8 914-924, Copyright © 1987 by American Diabetes Association

ARTICLES

Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates

DT Finegood, RN Bergman and M Vranic

Tracer methodology has been applied extensively to the estimation of endogenous glucose production (Ra) during euglycemic glucose clamps. The accuracy of this approach has been questioned due to the observation of significantly negative estimates for Ra when insulin levels are high. We performed hyperinsulinemic (300 microU/ml)-euglycemic glucose clamps for 180 min in normal dogs and compared the standard approach, an unlabeled exogenous glucose infusate (cold GINF protocol, n = 12), to a new approach in which a tracer (D-[3-3H]glucose) was added to the exogenous glucose used for clamping (hot GINF protocol, n = 10). Plasma glucose, insulin and glucagon concentrations, and glucose infusion rates were similar for the two protocols. Plasma glucose specific activity was 20 +/- 1% of basal (at 120-180 min) in the cold GINF studies, and 44 +/- 3 to 187 +/- 5% of basal in the hot GINF studies. With the one-compartment, fixed pool volume model of Steele, Ra for the cold GINF studies was -2.4 +/- 0.7 mg X min-1 X kg-1 at 25 min and remained significantly negative until 110 min (P less than .05). For the hot GINF studies, Ra was never significantly less than zero (P greater than .05) and was greater than in the cold GINF studies at 20-90 min (P less than .05). There was substantially less between-(78%) and within- (40%) experiment variation for the hot GINF studies compared with the cold GINF studies. An alternate approach (regression method) to the application of the one-compartment model, which allows for a variable and estimable effective distribution volume, yielded Ra estimates that were suppressed 60-100% from basal. In conclusion, the one-compartment, fixed pool volume model of glucose kinetics is inadequate for the estimation of Ra during euglycemic glucose clamps. Two new strategies for estimating Ra from the one-compartment model, the hot GINF protocol and the regression method calculation, yielded more accurate and physiologically plausible estimates of Ra than currently used methodology.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
S. Pereira, E. B. Marliss, J. A. Morais, S. Chevalier, and R. Gougeon
Insulin Resistance of Protein Metabolism in Type 2 Diabetes
Diabetes, January 1, 2008; 57(1): 56 - 63.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
E. Park, V. Wong, X. Guan, A. I Oprescu, and A. Giacca
Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo
J. Endocrinol., November 1, 2007; 195(2): 323 - 331.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
B. C. Bergman, M.-A. Cornier, T. J. Horton, and D. H. Bessesen
Effects of fasting on insulin action and glucose kinetics in lean and obese men and women
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1103 - E1111.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. R. Soeters, H. P. Sauerwein, J. E. Groener, J. M. Aerts, M. T. Ackermans, J. F. C. Glatz, E. Fliers, and M. J. Serlie
Gender-Related Differences in the Metabolic Response to Fasting
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3646 - 3652.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. P. Kim, K. J. Catalano, I. R. Hsu, J. D. Chiu, J. M. Richey, and R. N. Bergman
Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1590 - E1598.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. P. Kim, M. Ellmerer, E. L. Kirkman, and R. N. Bergman
beta-Cell "rest" accompanies reduced first-pass hepatic insulin extraction in the insulin-resistant, fat-fed canine model
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1581 - E1589.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Lindberg-Larsen, N. Moller, O. Schmitz, S. Nielsen, M. Andersen, H. Orskov, and J. O. L. Jorgensen
The Impact of Pegvisomant Treatment on Substrate Metabolism and Insulin Sensitivity in Patients with Acromegaly
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1724 - 1728.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. J. Guelfi, N. Ratnam, G. A. Smythe, T. W. Jones, and P. A. Fournier
Effect of intermittent high-intensity compared with continuous moderate exercise on glucose production and utilization in individuals with type 1 diabetes
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E865 - E870.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. C. Carpentier, F. Frisch, P. Brassard, F. Lavoie, A. Bourbonnais, D. Cyr, R. Giguere, and J.-P. Baillargeon
Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E693 - E701.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. J. Serlie, G. Allick, J. E. Groener, M. T. Ackermans, R. Heijligenberg, B. C. Voermans, J. M. Aerts, A. J. Meijer, and H. P. Sauerwein
Chronic Treatment with Pioglitazone Does Not Protect Obese Patients with Diabetes Mellitus Type II from Free Fatty Acid-Induced Insulin Resistance
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 166 - 171.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Chokkalingam, K. Jewell, L. Norton, J. Littlewood, L. J. C. van Loon, P. Mansell, I. A. Macdonald, and K. Tsintzas
High-Fat/Low-Carbohydrate Diet Reduces Insulin-Stimulated Carbohydrate Oxidation but Stimulates Nonoxidative Glucose Disposal in Humans: An Important Role for Skeletal Muscle Pyruvate Dehydrogenase Kinase 4
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 284 - 292.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
K.-A. Le, D. Faeh, R. Stettler, M. Ith, R. Kreis, P. Vermathen, C. Boesch, E. Ravussin, and L. Tappy
A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans
Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1374 - 1379.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Klip and M. Vranic
Muscle, liver, and pancreas: Three Musketeers fighting to control glycemia.
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1141 - E1143.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
N. Gupta, E. Park, H. Sandhu, T. Goh, V. Tchipashvili, and A. Giacca
Direct and indirect effects of insulin on hepatic glucose production in diabetic depancreatized dogs during euglycemia.
J. Endocrinol., September 1, 2006; 190(3): 695 - 702.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. Saukkonen, F. Shojaee-Moradie, R. M. Williams, R. Amin, K. C. Yuen, A. Watts, C. L. Acerini, A. M. Umpleby, and D. B. Dunger
Effects of Recombinant Human IGF-I/IGF-Binding Protein-3 Complex on Glucose and Glycerol Metabolism in Type 1 Diabetes.
Diabetes, August 1, 2006; 55(8): 2365 - 2370.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. Krogh-Madsen, P. Plomgaard, K. Moller, B. Mittendorfer, and B. K. Pedersen
Influence of TNF-{alpha} and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans
Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E108 - E114.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Ellmerer, M. Hamilton-Wessler, S. P. Kim, K. Huecking, E. Kirkman, J. Chiu, J. Richey, and R. N. Bergman
Reduced Access to Insulin-Sensitive Tissues in Dogs With Obesity Secondary to Increased Fat Intake
Diabetes, June 1, 2006; 55(6): 1769 - 1775.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. Yoshii, T. K. T. Lam, N. Gupta, T. Goh, C. A. Haber, H. Uchino, T. T. Y. Kim, V. Z. Chong, K. Shah, I. G. Fantus, et al.
Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1089 - E1097.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
V. Rigalleau, M.-C. Beauvieux, J.-L. Gallis, H. Gin, P. Schneiter, and L. Tappy
Effects of hyperglycemia on glucose metabolism before and after oral glucose ingestion in normal men
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1198 - E1204.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. E. Inouye, J. T. Y. Yue, O. Chan, T. Kim, E. M. Akirav, E. Park, M. C. Riddell, E. Burdett, S. G. Matthews, and M. Vranic
Effects of Insulin Treatment without and with Recurrent Hypoglycemia on Hypoglycemic Counterregulation and Adrenal Catecholamine-Synthesizing Enzymes in Diabetic Rats
Endocrinology, April 1, 2006; 147(4): 1860 - 1870.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Kishore, I. Gabriely, M.-H. Cui, J. Di Vito, S. Gajavelli, J.-H. Hwang, and H. Shamoon
Role of Hepatic Glycogen Breakdown in Defective Counterregulation of Hypoglycemia in Intensively Treated Type 1 Diabetes
Diabetes, March 1, 2006; 55(3): 659 - 666.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Chevalier, S. C. Burgess, C. R. Malloy, R. Gougeon, E. B. Marliss, and J. A. Morais
The Greater Contribution of Gluconeogenesis to Glucose Production in Obesity Is Related to Increased Whole-Body Protein Catabolism
Diabetes, March 1, 2006; 55(3): 675 - 681.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
S. Chevalier, R. Gougeon, N. Choong, M. Lamarche, and J. A. Morais
Influence of adiposity in the blunted whole-body protein anabolic response to insulin with aging.
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2006; 61(2): 156 - 164.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Brackenridge, E. R. Pearson, F. Shojaee-Moradie, A. T. Hattersley, D. Russell-Jones, and A. M. Umpleby
Contrasting Insulin Sensitivity of Endogenous Glucose Production Rate in Subjects With Hepatocyte Nuclear Factor-1{beta} and -1{alpha} Mutations
Diabetes, February 1, 2006; 55(2): 405 - 411.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. Wang, Y. Wei, and M. J. Pagliassotti
Saturated Fatty Acids Promote Endoplasmic Reticulum Stress and Liver Injury in Rats with Hepatic Steatosis
Endocrinology, February 1, 2006; 147(2): 943 - 951.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. Hadigan, D. Kamin, J. Liebau, S. Mazza, S. Barrow, M. Torriani, R. Rubin, S. Weise, A. Fischman, and S. Grinspoon
Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E289 - E298.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. C. Camacho, D. B. Lacy, F. D. James, E. P. Donahue, and D. H. Wasserman
5-Aminoimidazole-4-carboxamide-1-{beta}-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin
Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1039 - E1043.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. Chevalier, E. B Marliss, J. A Morais, M. Lamarche, and R. Gougeon
Whole-body protein anabolic response is resistant to the action of insulin in obese women
Am. J. Clinical Nutrition, August 1, 2005; 82(2): 355 - 365.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
D. S. Hardin, J. Rice, R. C. Cohen, K. J. Ellis, and J. A. Nick
The Metabolic Effects of Pregnancy in Cystic Fibrosis
Obstet. Gynecol., August 1, 2005; 106(2): 367 - 375.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. N. Montoro, S. L. Kjos, M. Chandler, R. K. Peters, A. H. Xiang, and T. A. Buchanan
Insulin Resistance and Preeclampsia in Gestational Diabetes Mellitus
Diabetes Care, August 1, 2005; 28(8): 1995 - 2000.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. Faeh, K. Minehira, J.-M. Schwarz, R. Periasamy, S. Park, and L. Tappy
Effect of Fructose Overfeeding and Fish Oil Administration on Hepatic De Novo Lipogenesis and Insulin Sensitivity in Healthy Men
Diabetes, July 1, 2005; 54(7): 1907 - 1913.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Bugianesi, U. Pagotto, R. Manini, E. Vanni, A. Gastaldelli, R. de Iasio, E. Gentilcore, S. Natale, M. Cassader, M. Rizzetto, et al.
Plasma Adiponectin in Nonalcoholic Fatty Liver Is Related to Hepatic Insulin Resistance and Hepatic Fat Content, Not to Liver Disease Severity
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3498 - 3504.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Weiss, S. E. Taksali, S. Dufour, C. W. Yeckel, X. Papademetris, G. Cline, W. V. Tamborlane, J. Dziura, G. I. Shulman, and S. Caprio
The "Obese Insulin-Sensitive" Adolescent: Importance of Adiponectin and Lipid Partitioning
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3731 - 3737.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. Plank, M. Bodenlenz, F. Sinner, C. Magnes, E. Gorzer, W. Regittnig, L. A. Endahl, E. Draeger, M. Zdravkovic, and T. R. Pieber
A Double-Blind, Randomized, Dose-Response Study Investigating the Pharmacodynamic and Pharmacokinetic Properties of the Long-Acting Insulin Analog Detemir
Diabetes Care, May 1, 2005; 28(5): 1107 - 1112.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Binnert, M. Genoud, G. Seematter, A. Fekirini, V. Mooser, G. Waeber, and L. Tappy
Glucose-Induced Insulin Secretion in Dyslipidemic and Normolipidemic Patients With Normal Glucose Tolerance
Diabetes Care, May 1, 2005; 28(5): 1225 - 1227.
[Full Text] [PDF]

Home page
 DiabetesHome page
M. J.M. Serlie, J. H. de Haan, C. J. Tack, H. J. Verberne, M. T. Ackermans, A. Heerschap, and H. P. Sauerwein
Glycogen Synthesis in Human Gastrocnemius Muscle Is Not Representative of Whole-Body Muscle Glycogen Synthesis
Diabetes, May 1, 2005; 54(5): 1277 - 1282.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
I. Gabriely and H. Shamoon
Fructose Normalizes Specific Counterregulatory Responses to Hypoglycemia in Patients With Type 1 Diabetes
Diabetes, March 1, 2005; 54(3): 609 - 616.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Ader, S. P. Kim, K. J. Catalano, V. Ionut, K. Hucking, J. M. Richey, M. Kabir, and R. N. Bergman
Metabolic Dysregulation With Atypical Antipsychotics Occurs in the Absence of Underlying Disease A Placebo-Controlled Study of Olanzapine and Risperidone in Dogs
Diabetes, March 1, 2005; 54(3): 862 - 871.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
V. B. Ritov, E. V. Menshikova, J. He, R. E. Ferrell, B. H. Goodpaster, and D. E. Kelley
Deficiency of Subsarcolemmal Mitochondria in Obesity and Type 2 Diabetes
Diabetes, January 1, 2005; 54(1): 8 - 14.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Ellmerer, S. P. Kim, M. Hamilton-Wessler, K. Hucking, E. Kirkman, and R. N. Bergman
Physiological Hyperinsulinemia in Dogs Augments Access of Macromolecules to Insulin-Sensitive Tissues
Diabetes, November 1, 2004; 53(11): 2741 - 2747.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
L. Perreault, J. M. Lavely, B. C. Bergman, and T. J. Horton
Gender differences in insulin action after a single bout of exercise
J Appl Physiol, September 1, 2004; 97(3): 1013 - 1021.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Yuen, J. Frystyk, M. Umpleby, L. Fryklund, and D. Dunger
Changes in Free Rather Than Total Insulin-Like Growth Factor-I Enhance Insulin Sensitivity and Suppress Endogenous Peak Growth Hormone (GH) Release following Short-Term Low-Dose GH Administration in Young Healthy Adults
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3956 - 3964.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Raji, M. D. Gerhard-Herman, M. Warren, S. G. Silverman, V. Raptopoulos, C. S. Mantzoros, and D. C. Simonson
Insulin Resistance and Vascular Dysfunction in Nondiabetic Asian Indians
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3965 - 3972.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. C. Camacho, D. B. Lacy, F. D. James, R. H. Coker, and D. H. Wasserman
Hepatic glucose autoregulation: responses to small, non-insulin-induced changes in arterial glucose
Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E269 - E274.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. N. Clore, J. S. Stillman, J. Li, S. J. D. O'Keefe, and J. R. Levy
Differential effect of saturated and polyunsaturated fatty acids on hepatic glucose metabolism in humans
Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E358 - E365.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. B. Degn, C. B. Juhl, J. Sturis, G. Jakobsen, B. Brock, V. Chandramouli, J. Rungby, B. R. Landau, and O. Schmitz
One Week's Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and {alpha}- and {beta}-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes
Diabetes, May 1, 2004; 53(5): 1187 - 1194.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. C. Camacho, R. R. Pencek, D. B. Lacy, F. D. James, and D. H. Wasserman
Suppression of Endogenous Glucose Production by Mild Hyperinsulinemia During Exercise Is Determined Predominantly by Portal Venous Insulin
Diabetes, February 1, 2004; 53(2): 285 - 293.
[Abstract] [Full Text]

Home page
 DiabetesHome page
M. Hawkins, J. Tonelli, P. Kishore, D. Stein, E. Ragucci, A. Gitig, and K. Reddy
Contribution of Elevated Free Fatty Acid Levels to the Lack of Glucose Effectiveness in Type 2 Diabetes
Diabetes, November 1, 2003; 52(11): 2748 - 2758.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. P. Kim, M. Ellmerer, G. W. Van Citters, and R. N. Bergman
Primacy of Hepatic Insulin Resistance in the Development of the Metabolic Syndrome Induced by an Isocaloric Moderate-Fat Diet in the Dog
Diabetes, October 1, 2003; 52(10): 2453 - 2460.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. J. Woerle, C. Meyer, E. M. Popa, P. E. Cryer, and J. E. Gerich
Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes: Further Evidence for Hepatorenal Reciprocity
Diabetes, June 1, 2003; 52(6): 1386 - 1392.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Ellmerer, M. Hamilton-Wessler, S. P. Kim, M. K. Dea, E. Kirkman, A. Perianayagam, J. Markussen, and R. N. Bergman
Mechanism of Action in Dogs of Slow-Acting Insulin Analog O346
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2256 - 2262.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
T. K. T. Lam, G. Van de Werve, and A. Giacca
Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites
Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E281 - E290.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. Raji, E. W. Seely, S. A. Bekins, G. H. Williams, and D. C. Simonson
Rosiglitazone Improves Insulin Sensitivity and Lowers Blood Pressure in Hypertensive Patients
Diabetes Care, January 1, 2003; 26(1): 172 - 178.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. Overkamp, A. Volk, E. Maerker, P. E. Heide, H. G. Wahl, K. Rett, and H. U. Haring
Acute Effect of Glimepiride on Insulin-Stimulated Glucose Metabolism in Glucose-Tolerant Insulin-Resistant Offspring of Patients With Type 2 Diabetes
Diabetes Care, November 1, 2002; 25(11): 2065 - 2073.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
N. Gupta, H. Sandhu, T. Goh, K. Shah, S. R. Wiesenthal, H. Yoshii, V. Chong, T. K. T. Lam, C. A. Haber, W. Williams, et al.
Insulin inhibits glucose production by a direct effect in diabetic depancreatized dogs during euglycemia
Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1002 - E1007.
[Abstract] [Full Text] [PDF]